Skip to main content

CLASS NOTES

Summer 2024
1989

Timothy Walbert

Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.

Go to Muhlenberg.edu